Ibnu Purwanto

5PUBLICATIONS
18CO-AUTHORS
Epidemiological methodsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 23, 2026
Direct and Indirect Associations of Sociodemographic Factors and Patient-Perceived Barriers With Delayed Breast Cancer Presentation: A Cross-Sectional Path Analysis.

|Apr 28, 2026
Adverse Prognostic Significance of Activation-Induced Cytidine Deaminase in Diffuse Large B-Cell Lymphoma Patients Treated With R-CHOP.

|Jan 28, 2025
Severe Deficiency of Vitamin D and Anthracycline-Taxane Regimen are associated with Cachexia Following Breast Cancer Chemotherapy: A Single Center Assessment Using Two Consensus-Based Criteria.

Susanna Hilda Hutajulu, Sofi Aresy, Yufi Kartika Astari

|Aug 03, 2023
Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression.

Ibnu Purwanto, Benedreky Leo, Susanna Hilda Hutajulu

|Aug 29, 2022
Stromal Tumor Infiltrating Lymphocytes (sTILs) Were Associated with a Higher Grade and a Lower Stage of Indonesian Triple Negative Breast Cancers.

Irianiwati Widodo, Ahmad Ghozali, Ibnu Purwanto

Pageof 1

Frequent Collaborators

4 joint publications

Susanna Hilda Hutajulu

3 joint publications

Kartika Widayati Taroeno-Hariadi

3 joint publications

Mardiah Suci Hardianti

3 joint publications

Johan Kurnianda